Evidence map›Paper›PMID 23959984›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2013

Primary marrow-derived stromal cells: isolation and manipulation.

Aravind Ramakrishnan, Beverly Torok-Storb, Manoj M Pillai

Open access · greenAbstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
9.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Control of cell behaviour through nanovibrational stimulation: nanokicking.Philosophical transactions. Series A, Mathematical, physical, and engineering sciences · 2018
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Aravind RamakrishnanClinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
Beverly Torok-Storb
Manoj M Pillai
Fred Hutch Cancer Center · USUniversity of Colorado Anschutz Medical Campus · US

Funding

CORE--VECTOR PRODUCTIONP30DK056465 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI HARKEY, MICHAEL A · 1999 to 2014
$14.9M
Vascularization and Growth of Human Myocardial GraftsP01HL094374 · NHLBI · UNIVERSITY OF WASHINGTON · PI LAFLAMME, MICHAEL ALAN · 2010 to 2014
$14.5M
Controlling Hematopoietic Lineage Commitment from ESC to PlateletsU01HL099993 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI TOROK-STORB, BEVERLY J. · 2009 to 2015
$8.3M
Role of microRNAs in regulation of the marrow microenvironmentR01HL104070 · NHLBI · YALE UNIVERSITY · PI PILLAI, MANOJ M. · 2011 to 2015
$2.2M
Generating iPS cells by reprogramming using small moleculesK08DK082783 · NIDDK · FRED HUTCHINSON CANCER RESEARCH CENTER · PI RAMAKRISHNAN, ARAVIND · 2009 to 2013
$671k
Monocyte derived CXCL7 in the marrow microenvironmentK08DK073701 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI PILLAI, MANOJ M. · 2006 to 2010
$641k
Role of macrophages in MSC-mediated recovery of hematopoiesis after irradiationR03DK082757 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI PILLAI, MANOJ M. · 2009 to 2010
$137k
NHLBI NIH HHS HL099993NHLBI NIH HHS HL104070NHLBI NIH HHS P01 HL094374NHLBI NIH HHS R01 HL104070NHLBI NIH HHS U01 HL099993NIDDK NIH HHS DK056465NIDDK NIH HHS DK073701NIDDK NIH HHS DK082757NIDDK NIH HHS DK082783NIDDK NIH HHS K08 DK073701NIDDK NIH HHS K08 DK082783NIDDK NIH HHS P30 DK056465NIDDK NIH HHS R03 DK082757
6 · The paper itself

Abstract

Marrow stromal cells (MSCs) are relatively rare cells difficult to visualize in marrow biopsies or detect in aspirated marrow. Under specific conditions MSC can be expanded in vitro and the population can give rise to several mesenchymal lineages. "MSC" also refers to mesenchymal stem cells which implies that all cells in the population are multipotent. It is generally agreed that while there may be a few multipotent stem cells in an MSC population the majority are not stem cells. In either case MSCs do not produce hematopoietic cells. Although MSCs have been isolated and characterized from several tissues, bone marrow is their most common source for research and clinical use. Primary MSC populations can be derived from bone marrow mononuclear cells with relative ease, but it is important to recognize the cellular heterogeneity within a culture and how this may vary from donor to donor. In this chapter, we describe methodology to derive primary MSCs from bone marrow screens, an otherwise discarded by-product of bone marrow harvests used for clinical transplantation. We also describe some useful techniques to characterize and manipulate MSCs-both primary and immortalized cell lines.

Indexed as

CD146 AntigenCells, CulturedCell SeparationCulture MediaFlow CytometryHumansMesenchymal Stem CellsPrimary Cell CultureTransfectionCD146 AntigenCulture MediaMCAM protein, human

Identifiers

PMID23959984
PMCPMC3748384
OpenAlexW94567555

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.